RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
186 hedge funds and large institutions have $2.13B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2020 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 66 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
186
Holders Change
-21
Holders Change %
-10.14%
% of All Funds
3.76%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.14%
New
27
Increased
69
Reduced
66
Closed
47
Calls
$36.9M
Puts
$29.6M
Net Calls
+$7.36M
Net Calls Change
-$12M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$49.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$24.2M |
| 3 |
DM
Deerfield Management
New York
|
+$18.1M |
| 4 |
CA
Corriente Advisors
Fort Worth,
Texas
|
+$14.9M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$13.2M |
